Literature DB >> 9063736

Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia.

T M Strom1, F Francis, B Lorenz, A Böddrich, M J Econs, H Lehrach, T Meitinger.   

Abstract

X-linked hypophosphatemic rickets in humans is caused by mutations in the PEX gene which codes for a protein homologous to neutral endopeptidases. Hyp and Gy mice both have X-linked hypophosphatemic rickets, although genetic data and the different phenotypic spectra observed have previously suggested that two different genes are mutated. In addition to the metabolic disorder observed in Hyp mice, male Gy mice are sterile and show circling behavior and reduced viability. We now report the cloning of the mouse homolog of PEX which is highly conserved between man and mouse. The 3' end of this gene is deleted in Hyp mice. In Gy mice, the first three exons and the promotor region are deleted. Thus, Hyp and Gy are allelic mutations and both provide mouse models for X-linked hypophosphatemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063736     DOI: 10.1093/hmg/6.2.165

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 3.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

4.  Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to 1,3-bis-(2-chloroethyl)-N-nitrosourea.

Authors:  C A Mackintosh; A E Pegg
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

5.  Identification of osteocyte-selective proteins.

Authors:  Dayong Guo; Andrew Keightley; Jill Guthrie; Patricia A Veno; Stephen E Harris; Lynda F Bonewald
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

6.  Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone.

Authors:  C Barragan-Adjemian; D Nicolella; V Dusevich; M R Dallas; J D Eick; L F Bonewald
Journal:  Calcif Tissue Int       Date:  2006-11-14       Impact factor: 4.333

7.  High bone mineral apparent density in children with X-linked hypophosphatemia.

Authors:  S S Beck-Nielsen; K Brixen; J Gram; C Mølgaard
Journal:  Osteoporos Int       Date:  2013-02-07       Impact factor: 4.507

8.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

9.  Effect of spermine synthase on the sensitivity of cells to anti-tumour agents.

Authors:  Yoshihiko Ikeguchi; Caroline A Mackintosh; Diane E McCloskey; Anthony E Pegg
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

10.  Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse.

Authors:  Catherine A Brownstein; Junhui Zhang; Althea Stillman; Bruce Ellis; Nancy Troiano; Douglas J Adams; Caren M Gundberg; Richard P Lifton; Thomas O Carpenter
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.